| Literature DB >> 29315325 |
Karlijn J Joling1, Liza van Eenoo2, Davide L Vetrano3,4,5, Veerle R Smaardijk1, Anja Declercq2, Graziano Onder3, Hein P J van Hout1, Henriëtte G van der Roest1.
Abstract
BACKGROUND: Health care systems that succeed in preventing long term care and hospital admissions of frail older people may substantially save on their public spending. The key might be found in high-quality care in the community. Quality Indicators (QIs) of a sufficient methodological level are a prerequisite to monitor, compare, and improve care quality. This systematic review identified existing QIs for community care for older people and assessed their methodological quality.Entities:
Mesh:
Year: 2018 PMID: 29315325 PMCID: PMC5760020 DOI: 10.1371/journal.pone.0190298
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1PRISMA flow diagram of the selection process.
Characteristics of the included quality indicator sets, presented by type of community care setting.
| Author, year, (name QI set, if applicable) | Country | Aim QI set | Number of QIs | Setting | Study population (sample size) |
|---|---|---|---|---|---|
| United Kingdom | Performance of home care services for people with dementia | Total: 52 | Home care services | Older people with dementia and/or their informal carers receiving home care services (n = 113 services, with 229 clients) | |
| USA | Nurse-physician communication | Total: 3 | Integrated home health care | Frail community-dwelling older adults with long-term care needs (sample size differed per QI and measurement from n = 30 to n = 394) | |
| Europe | Home care services quality | Total: 23 | Home care organizations | Persons aged 65 and older receiving community care services (e.g. home care) for at least two weeks (n = 1,354) | |
| United Kingdom | Home care services quality (service user experiences) | Total: 2 | Home care services | Home care service users aged 65 and older (n = 21,350) | |
| Taiwan | Quality of care for disabled older patients residing at home (vs. those residing in institutions) | Total: 5 | Home care (nursing care and doctors’ visits) | Disabled older patients aged 65 years and older who resided at home or in institutions and had submitted a first claim for coverage of National Health Insurance for home care over a 2-year period. | |
| Sweden | Structure quality and patient satisfaction with home care services | Total: 6 | Home-based services | Older persons aged 65 years and older using home-based and nursing home care services (n = 61,600 in home care; n = 33,400 in nursing homes) | |
| Europe | Quality of home care for people with dementia | Total: 8 | Home care | People with dementia aged 65 years and older with an MMSE ≤24, who received home care and were at risk of admission to a long-term care facility within 6 months (n = 1,223 people living at home; n = 791 in institutional care) | |
| United Kingdom | Three components of poor clinical care for elderly people: 1) insufficient use of beneficial drugs; 2) poor monitoring of chronic disease; 3) overuse of inappropriate or unnecessary drugs | Total: 15 | Primary care delivered by GPs | Elderly people aged 65 and older registered with general practices (people living at home were compared with people living in nursing homes). Excluded: Patients with terminal illness. (n = 526 people living at home; n = 172 in nursing homes) | |
| USA | Medication prescribing quality | Total: 4 | Primary care services | Older veterans aged 65 years and older, receiving Veterans Affairs primary care services (n = 1,549,824) | |
| Netherlands | Primary dementia care quality (diagnosis and management) | Total: 23 Outcome: 1 Process: 18 Structure: 4 | Primary care (general practices) | Frail elderly people, suspected of suffering from cognitive problems (n = 63) | |
| United Kingdom | Chronic disease management (coronary heart disease,stroke, atrial fibrillation, and diabetes) | Total: 16 | Primary care delivered by GPs | Residents of care homes and community-dwelling people aged 65 to 104 who were registered for at least 90 days with their general practitioner. Excluded: patients with exceptions (including disease wide exceptions, contraindications for a specific intervention or unavailability of a service or refusal of a specific intervention). (n = 403,259 people in the community; n = 10 387 residents in care homes) | |
| Sweden | Diabetes care quality according to national guidelines | Total: 16 | Primary health care centers | Elderly people aged 80 and older, with diabetes living at home with home health care (compared with elderly without home health care and residents of nursing homes). Excluded: patients who were no longer residents of the municipality, or with an incorrect diagnosis of diabetes, or entered a palliative phase or died. (n = 277) | |
| Netherlands | General practice care quality for vulnerable elders (focus on 8 conditions that are associated with the development of frailty) | Total: 81 | General practice care | Vulnerable elders, defined as community-dwelling individuals aged 65 and older who are at greater risk of death or functional decline over a 2-year period. (n = 950 [ | |
| USA | Adherence to dementia guidelines recommendations (assessment, treatment, education and support, safety) | Total: 22 | Primary care clinics and community agencies | Patients with dementia aged 65 and older and their informal caregivers | |
| USA | Potentially preventable hospitalization for ambulatory care sensitive conditions (i.e. hospitalizations that may be preventable with high quality primary and preventive care) | Total: 8 | Outpatient care | Elders aged 65 years and older | |
| USA | Process-of-care quality of the medical care provided to vulnerable elders (26 conditions most important to vulnerable elders) | Total: 342 | Community care | Vulnerable elders, defined as community-dwelling individuals aged 65 and older who are at greater risk of death or functional decline over a 2-year period. (n = 485 [ | |
| Canada | Care and services quality for vulnerable older adults with cognitive impairment or dementia | Total: 72 | Integrated community care | Vulnerable older adults with cognitive impairment/dementia and being treated in an integrated service system. The pilot study included 40 community-dwelling patients aged 75 and older with a diagnosis of cognitive impairment/dementia receiving home care services. (n = 40) | |
Abbreviations: QI, Quality Indicator; AHRQ, Agency for Healthcare Research & Quality
a The interRai-HCQI set has been used worldwide in countries participating in the InterRai network
b Two quality measures were excluded as these were not expressed with a numerator and denominator.
c Two structural QIs used in this study were only applied in the nursing home setting, and therefore not included in this review
d The following 8 European countries participated in this study: England, Estonia, Finland, France, Germany, the Netherlands, Spain, Sweden.
e One QI used in this study to assess the subjective quality of home care was not expressed with a numerator and denominator, and therefore not included in this review.
f Askari et al. (2016) used 9 (out of the 12 original) ACOVE fall-related QIs that were slightly adapted for the Dutch primary care setting by Van der Ploeg et al. (2008)
g Van der Ploeg et al. (2008) described a shortened and adapted version of the ACOVE-3 QI set for Dutch primary care. In S2 Appendix, we only extracted the QIs which were newly added (n = 5) or changed significantly (n = 4) compared with the original set. The (highly) overlapping QIs are only listed in the original set (Wenger et al., 2007).
h Although these QIs were measured with hospital inpatient data, they are aimed to provide insight into the quality of the ambulatory health care system, and seen by the developers as indirect measures of access to health care and quality of primary care in a community.
i The total set included 392 QIs. Of these, 50 QIs focused on elders receiving hospital or nursing home care and were thus excluded for this study.
j The 57 QIs from the ACOVE indicator set are not presented in the overview of the QIs (S2 Appendix), because the updated ACOVE set was extracted from Wenger et al. (2007).
Number of quality indicators per domain and disease, presented by type of indicator, and by type of community care setting.
| Domain | Type of indicator | Community care setting | ||||||
|---|---|---|---|---|---|---|---|---|
| Clinical issues | 27 | 328 | 0 | 355 | 18 | 53 | 284 | 355 |
| Screening and prevention | 0 | 21 | 0 | 21 | 1 | 6 | 14 | 21 |
| Medication | 3 | 97 | 0 | 100 | 1 | 16 | 83 | 100 |
| Non-pharmacological treatment | 0 | 90 | 0 | 90 | 0 | 2 | 88 | 90 |
| Clinical events and targets | 24 | 3 | 0 | 27 | 16 | 8 | 3 | 27 |
| Follow-up, monitoring and examinations | 0 | 134 | 0 | 134 | 0 | 22 | 112 | 134 |
| Cognition/ Mental health | 7 | 59 | 1 | 67 | 7 | 16 | 44 | 67 |
| Structure of care | 0 | 0 | 59 | 59 | 54 | 4 | 1 | 59 |
| Continuity and coordination of care | 0 | 35 | 1 | 36 | 3 | 9 | 24 | 36 |
| Psycho-social aspects | 3 | 23 | 1 | 27 | 3 | 5 | 19 | 27 |
| Functional performance | 4 | 22 | 0 | 26 | 5 | 1 | 20 | 26 |
| End of life | 0 | 18 | 0 | 18 | 0 | 0 | 18 | 18 |
| Patient perceptions and interaction | 0 | 15 | 0 | 15 | 6 | 2 | 7 | 15 |
| Service utilization | 12 | 2 | 0 | 14 | 3 | 1 | 10 | 14 |
| Not disease-specific | 31 | 149 | 2 | 182 | 39 | 13 | 130 | 182 |
| Dementia | 7 | 74 | 57 | 138 | 60 | 24 | 54 | 138 |
| Cancer | 0 | 65 | 0 | 65 | 0 | 0 | 65 | 65 |
| Cardiovascular | 0 | 61 | 0 | 61 | 0 | 11 | 50 | 61 |
| Diabetes Mellitus | 15 | 29 | 0 | 44 | 0 | 25 | 19 | 44 |
| Depression | 0 | 25 | 0 | 25 | 0 | 6 | 19 | 25 |
| COPD | 0 | 12 | 0 | 12 | 0 | 1 | 11 | 12 |
| Falls and mobility disorders | 0 | 12 | 0 | 12 | 0 | 0 | 12 | 12 |
| Hypothyroidism | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 |
| Osteoarthritis | 0 | 20 | 0 | 20 | 0 | 0 | 20 | 20 |
| Sleep disorders | 0 | 10 | 0 | 10 | 0 | 0 | 10 | 10 |
| Pulmonary disease | 0 | 4 | 0 | 4 | 0 | 0 | 4 | 4 |
| Renal and liver diseases | 0 | 2 | 0 | 2 | 0 | 0 | 2 | 2 |
| | 53 (9%) | 455 (80%) | 59 (10%) | |||||
| | 99 (17%) | 81 (14%) | 387 (68%) | |||||
*Quality Indicators could be included in more than one (sub)domain or cover more than one condition.
a included: Benign prostatic hyperplasia, breast cancer, colorectal cancer, lung cancer, cancer (not specified).
b included: Congestive heart failure, stroke, myocardial infarction, atrial fibrillation, coronary artery disease, coronary heart disease, heart disease, heart failure, ischaemic heart disease, ischaemic stroke, myocardial infarction, stroke, stroke and atrial fibrillation.
c [29, 38, 40, 42, 43, 47, 48]
d [31, 37, 39, 45, 46, 49]
e included: a combination of community care agencies and primary care clinics [34], outpatient care [28] and community care settings not further specified [36, 41]
Methodological characteristics of the quality indicator sets assessed with the AIRE instrument .
| Item | Venables [ | Kogan [ | Foebel [ | Jones [ | Chang [ | Kajonius [ | Beerens [ | Fahey [ | Lund [ |
| The group developing the indicator includes individuals from relevant professional groups | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1.5 | 4 |
| Considering the purpose of the indicator, all relevant stakeholders have been involved at some stage of the development process | 1 | 1 | 3.5 | 1 | 1 | 1 | 1 | 1.5 | 3 |
| The indicator has been formally endorsed | 1.5 | 1 | 3 | 2.5 | 1 | 2 | 1 | 1.5 | 1 |
| Systematic methods were used to search for scientific evidence | 1 | 2.5 | 1.5 | 1 | 1.5 | 1 | 2.5 | 1.5 | 2.5 |
| The indicator is based on recommendations from an evidence-based guideline | 3.5 | 2.5 | 2 | 1.5 | 2 | 2.5 | 3 | 1.5 | 3.5 |
| The supporting evidence has been critically appraised | 1 | 1 | 1 | 1 | 1 | 1 | 1.5 | 1 | 3 |
| The numerator and denominator are described in detail | 3 | 4 | 4 | 2 | 3.5 | 4 | 2.5 | 3.5 | 2 |
| The target patient population of the indicator is defined clearly | 2.5 | 3 | 3.5 | 3 | 4 | 3.5 | 4 | 3.5 | 4 |
| A strategy for risk adjustment has been considered and described | 1 | 1 | 4 | 1 | 2.5 | 1.5 | 1 | 3 | 2.5 |
| The indicator measures what it is intended to measure (validity) | 1 | 1.5 | 3.5 | 1.5 | 1 | 1 | 1.5 | 1 | 2.5 |
| The indicator measures accurately and consistently (reliability) | 1 | 1.5 | 3.5 | 2.5 | 1 | 1 | 1 | 1 | 1 |
| The indicator has sufficient discriminative power | 1.5 | 1.5 | 4 | 1 | 3.5 | 2.5 | 2.5 | 2.5 | 3 |
| The indicator has been piloted in practice | 3 | 3 | 3,5 | 3 | 3 | 2,5 | 3 | 3 | 2,5 |
| The efforts needed for data collection have been considered | 2.5 | 2.5 | 2 | 2.5 | 3.5 | 2.5 | 2 | 2.5 | 2.5 |
| Specific instructions for presenting and interpreting the indicator results are provided | 2 | 3.5 | 3 | 3 | 3 | 3 | 3 | 3 | 2.5 |
| Item | Perry [ | Shah [ | Neumark [ | Van der Ploeg [ | Vickrey [ | Kim [ | Wenger [ | Kröger [ | |
| The group developing the indicator includes individuals from relevant professional groups | 4 | 2.5 | 1 | 4 | 3 | 3 | 4 | 4 | |
| Considering the purpose of the indicator, all relevant stakeholders have been involved at some stage of the development process | 4 | 2.5 | 1 | 3 | 3.5 | 2,5 | 3 | 3 | |
| The indicator has been formally endorsed | 1 | 1.5 | 1.5 | 1 | 1 | 1 | 1 | 1 | |
| Systematic methods were used to search for scientific evidence | 2.5 | 2.5 | 1.5 | 2.5 | 1.5 | 4 | 4 | 2 | |
| The indicator is based on recommendations from an evidence-based guideline | 3.5 | 2.5 | 3.5 | 3 | 4 | 3.5 | 4 | 3.5 | |
| The supporting evidence has been critically appraised | 1 | 1 | 1 | 1.5 | 1.5 | 4 | 3.5 | 1.5 | |
| The numerator and denominator are described in detail | 3.5 | 4 | 2.5 | 3.5 | 2.5 | 3.5 | 4 | 3.5 | |
| The target patient population of the indicator is defined clearly | 2.5 | 4 | 4 | 3 | 4 | 3.5 | 4 | 3 | |
| A strategy for risk adjustment has been considered and described | 1 | 3 | 1 | 1 | 2.5 | 3.5 | 2.5 | 1 | |
| The indicator measures what it is intended to measure (validity) | 3.5 | 3 | 1 | 3.5 | 1.5 | 3.5 | 4 | 4 | |
| The indicator measures accurately and consistently (reliability) | 4 | 1 | 1 | 1 | 3 | 2 | 2.5 | 2.5 | |
| The indicator has sufficient discriminative power | 3.5 | 3 | 2.5 | 1 | 3 | 2.5 | 2 | 1 | |
| The indicator has been piloted in practice | 3,5 | 2,5 | 3 | 1,5 | 3 | 2,5 | 2,5 | 3 | |
| The efforts needed for data collection have been considered | 2.5 | 3 | 3.5 | 1.5 | 2 | 4 | 2.5 | 2.5 | |
| Specific instructions for presenting and interpreting the indicator results are provided | 1 | 3 | 2.5 | 1 | 3 | 3 | 3 | 1 | |
Abbreviations: AIRE, Appraisal of Indicators through Research and Evaluation
a Available at: http://zorginzicht.garansys.nl/kennisbank/PublishingImages/Paginas/AIRE-instrument/AIRE%20Instrument%202.0.pdf. The complete AIRE Instrument contains a fourth category ‘‘Purpose, Relevance and Organizational Context,” which was not used in this review [15].
b 1 = “strongly disagree” (criterion was not met or no information was provided); 2–3 = “agree/ disagree” (not sure if the criterion was met); 4 = “strongly agree” (criterion was met).
c The domain scores were calculated with the formula: (total score—minimum possible score) / (maximum score—minimum possible score) x 100%. A higher standardized score indicates a higher methodological level (range 0–100%).